MedTrace Logo

Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors

NCT00954148 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2010-06-30

No results posted yet for this study

Summary

This is a comparison, at this VA Hospital,of routine multi-visit and multi-testing for solid tumor recurrence in four tumor groups to a limited scheduled 5 visit history/physical with PET/CT only, over a five year period. The purpose is to show through utilization of the single most sensitive and specific test currently available-PET/CT-that survival for patients in follow-up can be improved.(Plus lowering medical costs and increasing patient confidence and compliance with follow-up appointments).

Conditions

Interventions

PROCEDURE

PET/CT

5 visits with PET/CT as only testing

PROCEDURE

NCCN recommendations for solid tumor post treatment

12-14 visits with exams, blood tests, CTs and PET/CT

Sponsors & Collaborators

  • Dallas VA Medical Center

    lead FED

Principal Investigators

  • James LePage, PH.D · ACOS for Research VA North TX Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-05-31
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00954148 on ClinicalTrials.gov